Health Care
Regeneron Q4 profit soars 371%, beats estimates
Regeneron Pharmaceuticals Inc. (REGN) reported a 371% jump in earnings for the fourth quarter helped by higher product sales and…
Boston Scientific Q4 earnings beat on strong sales growth; stock moves up
Broad-based sales growth, marked by a double-digit increase in emerging markets, lifted Boston Scientific’s (BSX) fourth-quarter earnings, which surpassed the…
Humana’s stock gains as Q4 results top expectations
Humana Inc. (HUM) topped analysts’ expectations on revenue and earnings for the fourth quarter of 2018. Shares inched up slightly…
Eli Lilly Q4 profit misses estimates, cuts 2019 outlook
Eli Lilly and Company (LLY) swung to a profit in the fourth quarter from a loss last year, helped by…
Earnings: Array BioPharma delivers strong Q2 results, investors cheer
Array BioPharma (ARRY) reported 44% jump in second-quarter revenue to $82.5 million, driven by higher product sales and recognition of…
Gilead Sciences swings to profit in Q4, but misses estimates
Gilead Sciences (GILD) swung to a profit in the fourth quarter from a loss last year, helped by a plunge…
Earnings preview: Cardiovascular to drive Boston Scientific Q4 results
Boston Scientific Corporation (BSX) is set to report its fourth-quarter earnings results on Wednesday before the bell. The medical device…
Earnings preview: Medicare Advantage to drive Humana’s Q4 growth
The quarterly performance of healthcare companies will be closely watched this season, considering the hectic M&A activity the sector has…
Earnings Preview: New drugs to propel Eli Lilly forward
Eli Lilly and Company (LLY) is scheduled to report earnings results for the fourth quarter of 2018 on February 6,…
Alexion Pharma stock jumps after Q4 results top expectations
Benefitting from the continued sales growth across all markets, led by cancer drug Soliris, Alexion Pharma (ALXN) Monday reported a…